Clinical trial
Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study
NCT00425945 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00425945 |
|---|---|
| Title | Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study |
| Official title | Cardiovascular Effects of Pine Bark Extract |
| Lead sponsor | Stanford University, Other |
| Collaborators | Funded by Toyo Shinyaku Co Ltd |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Pine Bark Extract (Flavangenol®) |
| Enrollment | 130 |
| Start date | Oct 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jan 24, 2007 |
| Last update posted | Apr 2, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: